ClinicalTrials.Veeva

Menu

BABYDIET-Study - Primary Prevention of Type 1 Diabetes in Relatives at Increased Genetic Risk

I

Institut fur Diabetesforschung, Munich, Germany

Status

Unknown

Conditions

Type 1 Diabetes

Treatments

Other: Glutenfree diet during the first year of life

Study type

Interventional

Funder types

Other

Identifiers

NCT01115621
ZI310/14-1

Details and patient eligibility

About

The major goals of this project are to determine whether primary intervention through delayed introduction of dietary gluten is feasible and could reduce the incidence of islet autoimmunity in high-risk first degree relatives of patients with type 1 diabetes.

Enrollment

150 patients

Sex

All

Ages

Under 3 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Newborn offspring or siblings of patients with type 1 diabetes with a HLA genotype conferring a high diabetes risk

Exclusion criteria

  • If infants have an illness or birth defect that precludes long-term follow-up or involves use of treatment that may alter the natural history of diabetes

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

150 participants in 2 patient groups

Glutenfree diet
Active Comparator group
Description:
Glutenfree diet during the first year of life
Treatment:
Other: Glutenfree diet during the first year of life
Control - normal diet
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems